8-K

                          UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549


                            FORM 8-K


                         CURRENT REPORT

             Pursuant to Section 13 or 15(d) of the

                 Securities Exchange Act of 1934

  Date of Report (Date of earliest event reported) September 3,
                              2003


                 COMPETITIVE TECHNOLOGIES, INC.
     (Exact name of registrant as specified in its charter)



Delaware                 1-8696                   36-2664428
(State or other          (Commission File         (IRS Employer
jurisdiction             Number)                  Identification No.)
of incorporation)




1960 Bronson Road, Fairfield, Connecticut         06824
(Address of principal executive offices)         (Zip Code)



Registrant's  telephone number, including area code   (203)  255-6044


                         Not Applicable
  (Former Name or Former Address, if Changed Since Last Report)


Item 5.   Other Events and Regulation FD Disclosure.

     On September 3, 2003, the United States Court of Appeals for
the Federal Circuit affirmed the August 13, 2002 judgment of the
United States District Court for the District of Colorado in the
Materna(TM) litigation.  As a result of its contract with the
University of Colorado Foundation, Competitive Technologies, Inc.
(CTT) shares 18.2% of damages after attorneys' fees.  If this
judgment is not appealed, CTT's share would be approximately $4.7
million plus its proportionate share of interest.

     Although the defendant may appeal this judgment, based on
the language of this September 3, 2003 judgment, CTT's management
believes there is a reasonable possibility that this lawsuit will
finally be settled and it will receive its share of damages
finally awarded.  CTT has recorded no potential judgment proceeds
in its financial statements to date.  CTT will record revenue for
judgment proceeds when it receives them.

     (For further information related to this lawsuit, see the
discussion of Materna Litigation in Notes 9 and 11 to CTT's
Condensed Financial Statements in its report on Form 10-Q for the
quarterly period ended April 30, 2003.)

Item 7.   Financial Statements and Exhibits.

(c)  Exhibits.

     Exhibit No.    Description of Exhibit                  Page

     99.1           Registrant's press release dated
                    September 4, 2003                         3



                            Signature


     Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.


                                   COMPETITIVE TECHNOLOGIES, INC.
                                   Registrant


Date:  September 4, 2003           /s/  John B. Nano
By:  John B. Nano
                                        President and
                                        Chief Executive Officer

EX-99.1

                                                           Exhibit 99.1

     CTT CLIENTS' AWARD OF OVER $54 MILLION IN MATERNA LITIGATION
            AGAINST WYETH AFFIRMED BY FEDERAL CIRCUIT COURT

Fairfield, CT (September 4, 2003):  Competitive Technologies, Inc.
(AMEX: CTT) announced that the US Court of Appeals for the Federal
Circuit (CAFC) has affirmed the August 13, 2002 decision of US Senior
District Court Judge John Kane of the US District Court for the
District of Colorado for an approximate $54 million patent infringement
judgment for fraud and unjust enrichment against Wyeth's (NYSE: WYE)
American Cyanamid Co. unit, and in favor of CTT's client, the
University of Colorado.  CTT expects to receive approximately $4.7
million of the net proceeds recovered from Wyeth in this $54 million
award.

The litigation involves a prenatal vitamin supplement marketed by
American Cyanamid under the Materna(TM) name.  A preliminary opinion
issued in July 2000 found that Drs. Robert H. Allen and Paul A.
Seligman, CTT's clients at the University of Colorado are the sole
inventors of the improved formulation of the prenatal vitamin
supplement, and that American Cyanamid had been unjustly enriched.  The
second opinion, issued in August 2002 and now affirmed by the CAFC,
reiterated that opinion.

John B. Nano, President and CEO of CTT said, 'We applaud the CAFC
decision to affirm the District Court's findings in favor of our
clients and CTT, finally closing a litigation which began in 1993 for
product sales between 1984 and 1994.'

About Competitive Technologies, Inc.

Competitive Technologies, established in 1968, is a full service
technology transfer and licensing provider focused on the technology
needs of its customers and transforming those requirements into
commercially viable solutions.  CTT is a global leader in identifying,
developing and commercializing innovative technologies in life,
digital, nano, and physical sciences developed by universities,
companies and inventors.  The global market for technology transfer
services is estimated at $150 billion annually.  CTT maximizes the
value of intellectual assets for the benefit of its customers, clients
and shareholders.  Visit CTT's website: http://www.competitivetech.net

Statements about the Company's future expectations, including
development and regulatory plans, and all other statements in this
document other than historical facts are "forward-looking statements"
within the meaning of applicable Federal Securities Laws and are not
guarantees of future performance.  These statements involve risks and
uncertainties, including those set forth in Item 1 of the Company's
most recent Form 10-K and in CTT's other filings with the SEC, and are
subject to change at any time.  The Company's actual results could
differ materially from these forward-looking statements.  The Company
undertakes no obligation to update publicly any forward-looking
statement.

Direct inquiries to:
Johnnie D. Johnson, Strategic IR, Inc.
E-mail: jdjohnson@strategic-ir.com
Tel. (212) 754-6565; Fax (212) 754-4333
E-mail: ctt@competitivetech.net